Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Zydus Pharmaceuticals (USA) Inc

US Class III Ongoing · initiated 2025-12-19

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Novo Nordisk Inc.

US Class II Ongoing · initiated 2025-12-19

Presence of Particulate Matter: Hair was found in a prefilled syringe

Novo Nordisk Inc.

US Class II Ongoing · initiated 2025-12-19

Presence of Particulate Matter: Hair was found in a prefilled syringe

Sato Pharmaceutical Co., Ltd

US Class II Ongoing · initiated 2025-12-19

Failed Disintegration Specifications: above the time expected.

Imprimis NJOF, LLC

US Class II Ongoing · initiated 2025-12-18

Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC

US Class II Ongoing · initiated 2025-12-18

Presence of particulate matter - Glass like particles.

Imprimis NJOF, LLC

US Class II Ongoing · initiated 2025-12-18

Presence of particulate matter - Glass like particles.

Viazen Immunity

Canada Type III Ongoing · initiated 2025-12-18

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

Teva-Topilene Ointment 0.05%

Canada Type II Ongoing · initiated 2025-12-18

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

CareFusion 213, LLC

US Class II Ongoing · initiated 2025-12-17

Lack of Assurance of Sterlity

APO-TRAVOPROST-TIMOP PQ

Canada Type II Ongoing · initiated 2025-12-17

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health conce…

SpecGx, LLC

US Class II Ongoing · initiated 2025-12-16

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

SpecGx, LLC

US Class II Ongoing · initiated 2025-12-16

Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

Alembic Pharmaceuticals Limited

US Class III Ongoing · initiated 2025-12-16

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

NOVADOZ PHARMACEUTICALS LLC

US Class III Ongoing · initiated 2025-12-15

Failed Impurities/Degradation Specifications

StuffbyNainax

US Class I Ongoing · initiated 2025-12-15

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil

Merck Sharp & Dohme LLC

US Class II Ongoing · initiated 2025-12-12

Presence of particulate matter: potential presence of metal particulates in the product.

Merck Sharp & Dohme LLC

US Class II Ongoing · initiated 2025-12-12

Presence of particulate matter: potential presence of metal particulates in the product.

Medinatura New Mexico, inc.

US Class I Ongoing · initiated 2025-12-12

Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.

Medinatura New Mexico, inc.

US Class I Ongoing · initiated 2025-12-12

Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.

SUN PHARMA /TARO

US Class II Ongoing · initiated 2025-12-09

Failed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint

Nitrous Oxide Chargers

Canada Type I Ongoing · initiated 2025-12-09

Product safety. Do not inhale nitrous oxide products for recreational purposes.Seek immediate medical attention from a health care professional (physician, nurs…

Signature Formulations, LLC

US Class II Ongoing · initiated 2025-12-08

cGMP Deviations

Signature Formulations, LLC

US Class II Ongoing · initiated 2025-12-08

cGMP Deviations

Sure Hoof

Canada Type III Ongoing · initiated 2025-12-05

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concer…